HomeBUSINESS
BUSINESS

Drug Pricing Reform Could Cause “Crustal Change” in Industry Structure: Chugai President
(Feb.2.2018)

Chugai President and COO Tatsuro Kosaka
Japan’s drug pricing overhaul in April this year could cause a “crustal change” in its pharma industry structure in the medium to long term, Chugai Pharmaceutical President and COO Tatsuro Kosaka said at an earnings conference on February 1 ...
(LOG IN FOR FULL STORY)